Skip to content
Insider tapeLive · 7:51 PM ET
Watchlist

Eric L. Keller

CEO at Retension Pharmaceuticals, Inc. (RTSN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$250K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 13 NewSEC RTSNRetension Pharmaceuticals, Inc. Buy 20,800423,377 held (+5%) $12.00 $250K —
  • Buy

    CEO Eric L. Keller bought $250K of RTSN at $12.00 — first open-market purchase in our records.